prostatectomy

Robotic Prostatectomy Centers Rising in the UK

Robotic Prostatectomy Centers Rising in the UK

Radical prostatectomy centers that closed from '10 to '14 more likely in areas with strong competition.

Active Surveillance for Intermediate-risk Prostate Cancer Challenged

Active Surveillance for Intermediate-risk Prostate Cancer Challenged

By

Study reveals that a quarter of men with low-volume intermediate-risk prostate cancer had adverse pathologic features found at radical prostatectomy.

RP for Prostate Cancer May Not Offer Survival Advantage

RP for Prostate Cancer May Not Offer Survival Advantage

By

Randomized trial found no significant difference in all-cause and cancer-specific survival between radical prostatectomy and observation for localized prostate cancer.

Radical Prostatectomy Use for High-Risk Prostate Cancer Rises Sharply

Radical Prostatectomy Use for High-Risk Prostate Cancer Rises Sharply

By

Over a 10-year period, radical prostatectomy use increased steadily while radiotherapy use declined

Surgery May Offer Better Survival for Younger Men With High-risk PCa

Surgery May Offer Better Survival for Younger Men With High-risk PCa

By

Younger patients who chose surgery vs radiation for initial treatment had a 48% survival advantage.

Diminished QOL Reported More Than 10 Years After PCa Treatment

Diminished QOL Reported More Than 10 Years After PCa Treatment

By

Urinary incontinence and diminished sexual function were common after a median follow-up of nearly 15 years, study finds.

Salvage RARP Feasible After PCa Focal Therapy Failure

Salvage RARP Feasible After PCa Focal Therapy Failure

By

Overall complication rates were similar between primary and salvage RARP groups, but there were some notable differences in prognosis.

Earlier vs Later Prostate Cancer Recurrence Characterized

Earlier vs Later Prostate Cancer Recurrence Characterized

By

Pathologic Gleason scores, positive surgical margin rates, and PSA doubling times differentiate earlier from later biochemical recurrence after radical surgery.

Predictors of Post-RARP Readmission Identified

Predictors of Post-RARP Readmission Identified

By

Patients with longer hospital stays and pre-discharge complications were at increased risk of readmission within 30 days of discharge.

Nerve-sparing RP May Not Raise Positive Margin Risk

Nerve-sparing RP May Not Raise Positive Margin Risk

By

Researchers found no evidence of worse cancer outcomes with nerve-sparing surgery.

Prostate Cancer Treatment Prolongs Survival

Prostate Cancer Treatment Prolongs Survival

By

Study compared PCa patients who underwent surgery or radiation treatment with a matched group of non-cancer controls.

Autologous Urethral Sling Does Not Improve Continence After Prostatectomy

Autologous Urethral Sling Does Not Improve Continence After Prostatectomy

No benefit of autologous urethral sling placement at robotic assisted radical prostatectomy on early return of continence at 6 months.

Nearly 1 in 5 General Surgery Students Leave the Program

Nearly 1 in 5 General Surgery Students Leave the Program

The pooled estimate for the overall attrition prevalence was 18%, with significant variation between studies.

Complication Risk Due to Obesity Greater With Minimal Invasive RP

Complication Risk Due to Obesity Greater With Minimal Invasive RP

By

Obesity predicts a wider range of complications in PCa patients who undergo laparoscopic or robot-assisted versus open radical prostatectomy.

Prostate Cancer BCR Risk Not Linked to Statin Use

Prostate Cancer BCR Risk Not Linked to Statin Use

By

Over a median follow-up of 70 months, 15% of men studied experienced biochemical recurrence.

Racial Disparities Found in Prostate Cancer Treatment

Racial Disparities Found in Prostate Cancer Treatment

By

Within each D'Amico risk category, African-American and Hispanic prostate cancer patients were less likely to receive definitive treatment than white patients.

10-Year Mortality for Localized PCa Does Not Differ by Treatment Choice

10-Year Mortality for Localized PCa Does Not Differ by Treatment Choice

Ten-year mortality rates of prostate cancer are low, regardless of whether patients are treated with radiotherapy, surgery, or undergo only active surveillance.

Smokers Face Delayed Continence Recovery After Prostate Surgery

Smokers Face Delayed Continence Recovery After Prostate Surgery

By

Large prostates and bladder neck sparing also predict longer time to return of continence.

Cardiac Event Risk in PCa Patients Higher After Radiation Than Surgery

Cardiac Event Risk in PCa Patients Higher After Radiation Than Surgery

By

Radiation therapy also is associated with a greater likelihood of fractures.

PCa Surgery Patients Largely Unaware of Sexual Complications

PCa Surgery Patients Largely Unaware of Sexual Complications

By

Many men are unaware of erectile function recovery time and problems with ejaculation.

Superficial Sling Implantation Eases Post-RP Incontinence

Superficial Sling Implantation Eases Post-RP Incontinence

By

Modified technique improved stress urinary incontinence in nearly three-quarters of patients.

Erectile Dysfunction Drugs Do Not Affect Prostate Cancer Relapse Risk

Erectile Dysfunction Drugs Do Not Affect Prostate Cancer Relapse Risk

By

No significant association found between phosphodiesterase type 5 inhibitor use and biochemical recurrence after radical treatment.

Surgery for High-Risk PCa in Young Men Offers Good Long-Term Survival

Surgery for High-Risk PCa in Young Men Offers Good Long-Term Survival

By

In a study of patients aged 59 years or younger, cancer-specific and other-cause mortality rates at 20 years were 13.5% and 19.3%, respectively.

Surgery Offers Prostate Cancer Patients Better Survival Odds

Surgery Offers Prostate Cancer Patients Better Survival Odds

By

Men with clinically-localized tumors are more likely to die from any cause or from PCa if they undergo radiotherapy rather than radical prostatectomy, study finds.

Adjuvant, Salvage PCa Radiotherapy Long-Term Outcomes Similar

Adjuvant, Salvage PCa Radiotherapy Long-Term Outcomes Similar

By

New analysis shows no significant difference in 10-year progression-free and overall survival among men with high-risk prostate cancer.

Large Variation in Costs for Low-Risk Prostate Cancer Treatment

Large Variation in Costs for Low-Risk Prostate Cancer Treatment

Large cost variation over 12 years of follow-up due to equipment, visits.

Surgery Better for High-Risk Prostate Cancer

Surgery Better for High-Risk Prostate Cancer

By

Radical prostatectomy was associated with a higher biochemical recurrence-free survival rate compared with radiotherapy.

Inferior Care, Higher Costs for Black Prostate Cancer Patients

Inferior Care, Higher Costs for Black Prostate Cancer Patients

Problems include longer waits, greater need for more care after surgery, and rehospitalization.

Extended Pelvic Lymph Node Dissection Not Linked with ED, Incontinence

Extended Pelvic Lymph Node Dissection Not Linked with ED, Incontinence

By

After 2 years, continence, potency, and freedom from recurrence were achieved in almost half of men who had extended pelvic lymph node dissection.

Sign Up for Free e-newsletters